Tivpod-DX
Description_Effects
Tivpod-DX is a combination antibiotic medicine containing Cefpodoxime 200 mg and Dicloxacillin Sodium 500 mg (Extended Release). This formulation is designed to treat a wide range of bacterial infections by combining the strengths of two effective antibiotics. Cefpodoxime is a third-generation cephalosporin antibiotic that works by inhibiting the synthesis of the bacterial cell wall, leading to the destruction of bacteria. It is effective against a variety of gram-positive and gram-negative bacteria and is commonly used to treat respiratory tract infections, urinary tract infections, skin infections, and ENT infections. Dicloxacillin is a beta-lactam antibiotic that is resistant to penicillinase, an enzyme produced by some bacteria to inactivate penicillin. It is particularly effective against penicillin-resistant Staphylococcus aureus and other gram-positive organisms. The extended-release form of Dicloxacillin helps maintain stable blood levels over a longer period, enhancing the therapeutic effect and reducing the frequency of dosing. The combination of these two antibiotics ensures broad-spectrum antibacterial activity, covering both common and resistant bacterial strains. Tivpod-DX is often prescribed for conditions such as bronchitis, sinusitis, tonsillitis, skin and soft tissue infections, and bone infections. Common side effects may include nausea, diarrhea, abdominal pain, and skin rash. It is important to complete the full course of treatment as prescribed, even if symptoms improve early, to prevent resistance and ensure complete recovery. This medication should be used under medical supervision, especially in patients with allergies to beta-lactam antibiotics or those with kidney or liver impairment.
